Health Innovation North West Coast staff
The Innovation Agency has been renamed Health Innovation North West Coast.
The renaming follows NHS England’s decision to relicense England’s 15 Academic Health Science Networks (AHSNs) for a further five years until 2028.
The new title aims to better reflect the goals of Health Innovation North West Coast and its partner organisations – to boost the adoption and spread of innovations that improve patient outcomes.
Dr Phil Jennings, Chief Executive of Health Innovation North West Coast, said: “I’m hopeful the new name will become familiar to our partners in the region very quickly because our mission will remain the same, to drive the adoption of innovations that deliver better care.
“This new licence is recognition of the support we’ve given in the past decade to our colleagues in the health and care system as they tackle their challenges.
“It’s also a mandate to continue building relationships with health service colleagues, industry, academia and the third sector and bring a collaborative approach to spreading innovation.”
The relicensing allows Health Innovation North West Coast to continue to support healthcare systems partners in their patient safety and care improvement work.
It will also work to boost economic growth by supporting small companies – in the region and overseas – that develop health and care innovations.
AHSNs were launched in 2013 to act as the innovation arm of the NHS, supporting the spread of all types of innovation in the health and care system, including new technologies, new ways of working and service improvements.
In the North West Coast, the Innovation Agency has in the last 10 years:
- Delivered Restore2 training, designed to improve patient care, in more than 400 care homes
- Established a safety improvement programme for maternity services in all 11 maternity units in the region
- Secured £191m of inward investment
- Helped secure 689 jobs and supported more than 1,800 innovative companies
- Delivered coaching to around 3,000 individuals and teams
- Provided facilitation and coaching for system change programmes such as redesign of a pulmonary rehabilitation pathway; a new lipids pathway; development of a clinical and care system leadership framework
AHSNs have delivered 11 national adoption and spread programmes and supported the rapid uptake of 28 NICE-approved products. These initiatives alone have benefited more than 2.3 million patients. Since 2018, AHSNs have also helped to leverage investment of £1.8bn for the UK.
News and blogs >
Hospitals trial test to speed up diagnosis of children with infections Read more
An innovative 15-minute blood test which can fast-track the diagnosis of children with potentially life-threatening conditions is being trialled by the NHS in Liverpool this winter.
Partnerships pave the way to better outcomes Read more
The incoming chief executive of NHS Lancashire and South Cumbria has urged health and care leaders to strengthen cross-sector partnerships to help the region tackle its most intractable challenges.
Novartis partnership opportunity for “best access to the best care” Read more
We convened the Novartis UK senior leadership team and the Cheshire and Merseyside life sciences system to set ambitions and agree priorities for an exciting new partnership.
Funding boost for respiratory care Read more
Patients in Liverpool will benefit from the improved treatment of asthma and chronic obstructive pulmonary disorder (COPD) after the region won funding for a package of innovative projects.